Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 6-Diazo-5-oxo-L-norleucine, a new tumor-inhibitory substance. I. Biologic studies.

Literature DB >> 24544086

6-Diazo-5-oxo-L-norleucine, a new tumor-inhibitory substance. I. Biologic studies.

G L COFFEY, J EHRLICH, M W FISHER, A B HILLEGAS, D L KOHBERGER, H E MACHAMER, W A RIGHTSEL, F R ROEGNER.

Abstract

Entities: Chemical Disease

Keywords: BACTERIA/effect of drugs on; FUNGI/effect of drugs on; LEUCINE/related compounds

Mesh：

Substances：

Year: 1956 PMID： 24544086

Source DB: PubMed Journal: Antibiot Chemother (Northfield) ISSN： 0570-3123

Keyword Cloud
Cited

× No keyword cloud information.

11 in total

Review 1. Nontraditional microbial bioactive metabolites.

Authors: V Bĕhal
Journal: Folia Microbiol (Praha) Date: 2001 Impact factor: 2.099

Review 2. Mode of action of microbial bioactive metabolites.

Authors: V Bethal
Journal: Folia Microbiol (Praha) Date: 2006 Impact factor: 2.099

3. Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis.

Authors: Sivabalan Manivannan; Victoria K Baxter; Kimberly L W Schultz; Barbara S Slusher; Diane E Griffin
Journal: J Virol Date: 2016-09-29 Impact factor: 5.103

4. Pharmacokinetic and phase I study of intravenous DON (6-diazo-5-oxo-L-norleucine) in children.

Authors: M P Sullivan; J A Nelson; S Feldman; B Van Nguyen
Journal: Cancer Chemother Pharmacol Date: 1988 Impact factor: 3.333

Review 5. Targeting mitochondrial metabolism for precision medicine in cancer.

Authors: Lourdes Sainero-Alcolado; Judit Liaño-Pons; María Victoria Ruiz-Pérez; Marie Arsenian-Henriksson
Journal: Cell Death Differ Date: 2022-07-13 Impact factor: 12.067

Review 6. Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy.

Authors: Diana Cervantes-Madrid; Yair Romero; Alfonso Dueñas-González
Journal: Biomed Res Int Date: 2015-09-06 Impact factor: 3.411

Review 7. Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents.

Authors: Ian A Clark; Bryce Vissel
Journal: J Neuroinflammation Date: 2016-09-05 Impact factor: 8.322